Literature DB >> 22361098

Stability of influenza vaccine coated onto microneedles.

Hyo-Jick Choi1, Dae-Goon Yoo, Brian J Bondy, Fu-Shi Quan, Richard W Compans, Sang-Moo Kang, Mark R Prausnitz.   

Abstract

A microneedle patch coated with vaccine simplifies vaccination by using a patch-based delivery method and targets vaccination to the skin for superior immunogenicity compared to intramuscular injection. Previous studies of microneedles have demonstrated effective vaccination using freshly prepared microneedles, but the issue of long-term vaccine stability has received only limited attention. Here, we studied the long-term stability of microneedles coated with whole inactivated influenza vaccine guided by the hypothesis that crystallization and phase separation of the microneedle coating matrix damages influenza vaccine coated onto microneedles. In vitro studies showed that the vaccine lost stability as measured by hemagglutination activity in proportion to the degree of coating matrix crystallization and phase separation. Transmission electron microscopy similarly showed damaged morphology of the inactivated virus vaccine associated with crystallization. In vivo assessment of immune response and protective efficacy in mice further showed reduced vaccine immunogenicity after influenza vaccination using microneedles with crystallized or phase-separated coatings. This work shows that crystallization and phase separation of the dried coating matrix are important factors affecting long-term stability of influenza vaccine-coated microneedles. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22361098      PMCID: PMC3586192          DOI: 10.1016/j.biomaterials.2012.01.054

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  37 in total

1.  Bacillus Calmette-Guérin vaccination using a microneedle patch.

Authors:  Yasuhiro Hiraishi; Subhadra Nandakumar; Seong-O Choi; Jeong Woo Lee; Yeu-Chun Kim; James E Posey; Suraj B Sable; Mark R Prausnitz
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.

Authors:  Robert Alcock; Matthew G Cottingham; Christine S Rollier; Julie Furze; Samodh D De Costa; Marian Hanlon; Alexandra J Spencer; Jared D Honeycutt; David H Wyllie; Sarah C Gilbert; Migena Bregu; Adrian V S Hill
Journal:  Sci Transl Med       Date:  2010-02-17       Impact factor: 17.956

3.  Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis.

Authors:  Peter E Daddona; James A Matriano; Jaap Mandema; Yuh-Fun Maa
Journal:  Pharm Res       Date:  2010-06-22       Impact factor: 4.200

4.  Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.

Authors:  Xianfeng Chen; Germain J P Fernando; Michael L Crichton; Christopher Flaim; Sally R Yukiko; Emily J Fairmaid; Holly J Corbett; Clare A Primiero; Alexander B Ansaldo; Ian H Frazer; Lorena E Brown; Mark A F Kendall
Journal:  J Control Release       Date:  2011-03-01       Impact factor: 9.776

5.  Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

6.  Demonstrated solid-state stability of parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system.

Authors:  Mahmoud Ameri; Peter E Daddona; Yuh-Fun Maa
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

7.  Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.

Authors:  Dimitrios G Koutsonanos; Maria del Pilar Martin; Vladimir G Zarnitsyn; Joshy Jacob; Mark R Prausnitz; Richard W Compans; Ioanna Skountzou
Journal:  J Infect Dis       Date:  2011-06-17       Impact factor: 5.226

8.  Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.

Authors:  Holly J Corbett; Germain J P Fernando; Xianfeng Chen; Ian H Frazer; Mark A F Kendall
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

9.  Induction of heterosubtypic immunity to influenza virus by intranasal immunization.

Authors:  Fu-Shi Quan; Richard W Compans; Huan H Nguyen; Sang-Moo Kang
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 10.  Delivery systems for intradermal vaccination.

Authors:  Y C Kim; C Jarrahian; D Zehrung; S Mitragotri; M R Prausnitz
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

View more
  37 in total

Review 1.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

Review 2.  The success of microneedle-mediated vaccine delivery into skin.

Authors:  Sarah Marshall; Laura J Sahm; Anne C Moore
Journal:  Hum Vaccin Immunother       Date:  2016-04-06       Impact factor: 3.452

Review 3.  Recent advances of controlled drug delivery using microfluidic platforms.

Authors:  Sharma T Sanjay; Wan Zhou; Maowei Dou; Hamed Tavakoli; Lei Ma; Feng Xu; XiuJun Li
Journal:  Adv Drug Deliv Rev       Date:  2017-09-15       Impact factor: 15.470

4.  Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.

Authors:  Leonard Y Chu; Ling Ye; Ke Dong; Richard W Compans; Chinglai Yang; Mark R Prausnitz
Journal:  Pharm Res       Date:  2015-12-01       Impact factor: 4.200

Review 5.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

Review 6.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles.

Authors:  Hyo-Jick Choi; Brian J Bondy; Dae-Goon Yoo; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Control Release       Date:  2012-12-13       Impact factor: 9.776

8.  The osmotic stress response of split influenza vaccine particles in an acidic environment.

Authors:  Hyo-Jick Choi; Min-Chul Kim; Sang-Moo Kang; Carlo D Montemagno
Journal:  Arch Pharm Res       Date:  2013-10-08       Impact factor: 4.946

Review 9.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

Review 10.  Microneedle patches for vaccination in developing countries.

Authors:  Jaya Arya; Mark R Prausnitz
Journal:  J Control Release       Date:  2015-11-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.